Peptide record

TPDB11250

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11250
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 30-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GAFGNFLKGVAKKAGLKILSIAQCKLSGTC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C136H231N37O36S2
RDEHMPWY
GK
3024.68
10.39
5
0
13
+5
-0.16
0.513
101.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.04
7
Residue Composition
number
4
A
0
R
1
N
0
D
2
C
0
E
1
Q
5
G
0
H
2
I
4
L
5
K
0
M
2
F
0
P
2
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 2 E: 0 Q: 1 G: 5 H: 0 I: 2 L: 4 K: 5 M: 0 F: 2 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
30 reviewed residue count
C136H231N37O36S2 sequence-only estimate (linear, free termini)
3024.68 sequence-only estimate (linear, free termini)
10.39 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
-0.16 sequence-only estimate (linear, free termini)
0.513 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

% Hemolysis
Hemolysis
17 %
[Ref.21171145] It has 17% hemolysis at 100 µg/ml against rabbit red blood cell

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
J Pept Sci. 2011 Jan 17(1):68-72.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

17% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
17% Hemolysis | 100 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata. | J Pept Sci | 2011
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
17 %
Hemolytic
Hemolytic_activity: [Ref.21171145] It has 17% hemolysis at 100 µg/ml against rabbit red blood cell

Target

erythrocytes

Source & Reference

NA
DRAMP
J Pept Sci. 2011 Jan 17(1):68-72.
Evidence 4 Hemolysis

Activity

17 %
% Hemolysis
[Ref.21171145] It has 17% hemolysis at 100 µg/ml against rabbit red blood cell
Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
J Pept Sci. 2011 Jan 17(1):68-72.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.